News
July 9, 2013

Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor

US 8,481,535

Find more content tagged:

Related Content

October 6, 2021
Opportunity to Influence Rulemaking Under the California Privacy Rights Act
Advisory
October 5, 2021
Third Circuit: Section 230 Does Not Bar Pennsylvania Statutory Right of Publicity Claim Against Facebook
Advisory
September 27, 2021
FDA Seeks to Deepen Engagement with USPTO on Pharmaceutical Patents
Advisory
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept